BiotechTube
EPISKIN

EPISKIN

Lyon, France· Est.
episkin.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

EPISKIN is a pioneering and established player in the in vitro human tissue model space, operating at the intersection of biotechnology, cosmetics, and pharmaceuticals. The company leverages its proprietary tissue engineering platform to produce standardized, high-volume 3D human tissue models, which serve as critical tools for R&D, helping clients accelerate development and comply with the global shift away from animal testing. With a validated ISO 9001 production facility capable of delivering thousands of tissues weekly, EPISKIN has transitioned from a research innovator to a commercial-scale provider of essential testing tools, supported by a strong educational arm, the EPISKIN Academy. Its business is built on a B2B model, selling models and associated services to industrial and academic partners worldwide.

DermatologyOphthalmologyWomen's Health

Technology Platform

Proprietary tissue engineering platform for industrial-scale production of standardized, reproducible 3D reconstructed human tissues (epidermis, full-thickness skin, corneal epithelium, oral/gingival/vaginal mucosa) with defined histology and functionality.

Funding History

1
GrantUndisclosed

Opportunities

The global regulatory ban on animal testing for cosmetics and increasing restrictions in pharmaceuticals creates mandatory demand for validated alternative methods.
Expansion into new epithelial tissue models and deeper penetration into the pharmaceutical and chemical regulatory testing markets represent significant growth avenues.
The trend toward human-relevant data in research provides a strong tailwind for adoption beyond regulatory compliance.

Risk Factors

Dependence on the continued regulatory validation and acceptance of its specific test methods by authorities worldwide.
Competition from other tissue engineering firms and the potential for technological disruption by newer testing modalities.
Reliance on the cosmetic industry, which is subject to economic sensitivity, could create revenue volatility.

Competitive Landscape

EPISKIN operates in the niche market of in vitro human tissue models, competing with other specialized firms like MatTek (US), Phenion (Germany/Henkel), and SkinEthic (France/L'Oréal). It differentiates through its broad portfolio, industrial-scale production, and established regulatory validation for key tests. Large cosmetic and chemical companies may also develop in-house capabilities, representing both potential partners and competitors.

More companies in Regenerative Medicine →More companies in France →